News

Four doses of GP MDI were compared to placebo and Atrovent HFA Inhalation Aerosol, a short-acting muscarinic antagonist given four times a day (QID). All doses of GP

The study looks at the efficacy of the drug as well as continuing to look at the safety profile established in the Phase 1 trial. BC-IBU-CH-001 is a

PCI-32765 is an orally active, small molecule inhibitor of Bruton’s tyrosine kinase (Btk), an essential element of the B-cell antigen receptor (BCR) signaling pathway that causes tumor expansion.

As per the agreement, AstraZeneca will have access to injectable medicines used to treat infections and will make them available to patients in China. On completion of the

The 50/50 JV combines Microsoft’s platform expertise with GE Healthcare’s experience in clinical and administrative workflow solutions The JV will develop and market an open, interoperable technology platform

As part of the deal, Molecular Partners and Janssen Biotech will jointly develop DARPins and examine their use to address diseases where there is unmet needs for effective

Pycnogenol is an antioxidant plant extract from the bark of the French maritime pine tree. The study examined 53 Italian university students, aged 18-27, who were given 100

The Phase 3 program includes two randomized, double-blind, placebo-controlled studies, ULISES 007 and ULISES 008. The objective is to evaluate the efficacy and safety of daily 160 and

MelanPlus is believed to be a vitamin treatment for graying hair which addresses specific nutritional needs based on gender. According to the company, the new formulas contain Chinese